David M Heery
Overview
Explore the profile of David M Heery including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chrisp R, Masterson M, Pope R, Roberts C, Collins H, Watson D, et al.
Sci Rep
. 2025 Mar;
15(1):8347.
PMID: 40069567
NPAS2 (Neuronal PAS Domain Protein 2) is a component of the core circadian clock and the coordinated activity between central brain and peripheral liver clock proteins postulated to be instrumental...
2.
Pencik J, Philippe C, Schlederer M, Atas E, Pecoraro M, Grund-Groschke S, et al.
Mol Cancer
. 2023 Aug;
22(1):133.
PMID: 37573301
Prostate cancer (PCa) is a common and fatal type of cancer in men. Metastatic PCa (mPCa) is a major factor contributing to its lethality, although the mechanisms remain poorly understood....
3.
Monteiro C, Heery D, Whitchurch J
Adv Exp Med Biol
. 2023 Jul;
1429:13-40.
PMID: 37486514
Mice have been used in biological research for over a century, and their immense contribution to scientific breakthroughs can be seen across all research disciplines, with some of the main...
4.
Metzler V, de Brot S, Haigh D, Woodcock C, Lothion-Roy J, Harris A, et al.
Front Cell Dev Biol
. 2023 May;
11:1116424.
PMID: 37152294
Histone H3 lysine 4 (H3K4) methylation is key epigenetic mark associated with active transcription and is a substrate for the KDM1A/LSD1 and KDM5B/JARID1B lysine demethylases. Increased expression of KDM1A and...
5.
Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D, et al.
Cell Death Differ
. 2023 Apr;
30(5):1097-1154.
PMID: 37100955
Apoptosis is a form of regulated cell death (RCD) that involves proteases of the caspase family. Pharmacological and genetic strategies that experimentally inhibit or delay apoptosis in mammalian systems have...
6.
Wang T, Sarwar M, Whitchurch J, Collins H, Green T, Semenas J, et al.
Front Cell Dev Biol
. 2022 Apr;
10:798590.
PMID: 35386201
PIP5K1α has emerged as a promising drug target for the treatment of castration-resistant prostate cancer (CRPC), as it acts upstream of the PI3K/AKT signaling pathway to promote prostate cancer (PCa)...
7.
Larsson P, Karlsson R, Sarwar M, Miftakhova R, Wang T, Syed Khaja A, et al.
Mol Oncol
. 2021 Dec;
16(13):2496-2517.
PMID: 34932854
Low-affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa) is a cell surface protein that belongs to a family of Fc receptors that facilitate the protective function of the immune system...
8.
Aksoy O, Pencik J, Hartenbach M, Moazzami A, Schlederer M, Balber T, et al.
Int J Cancer
. 2020 Oct;
148(3):731-747.
PMID: 33034050
Androgen deprivation therapy (ADT) remains a key approach in the treatment of prostate cancer (PCa). However, PCa inevitably relapses and becomes ADT resistant. Besides androgens, there is evidence that thyroid...
9.
Kurozumi S, Alsaleem M, Monteiro C, Bhardwaj K, Joosten S, Fujii T, et al.
Breast Cancer Res
. 2020 Aug;
22(1):85.
PMID: 32782013
Background: Invasive lobular carcinoma (ILC) accounts for 10-15% of primary breast cancers and is typically estrogen receptor alpha positive (ER+) and ERBB2 non-amplified. Somatic mutations in ERBB2/3 are emerging as...
10.
Luveta J, Parks R, Heery D, Cheung K, Johnston S
Oncol Ther
. 2020 Jul;
8(1):1-11.
PMID: 32700069
Invasive lobular carcinoma comprises 10-15% of all breast cancers and is increasingly recognised as a distinct and understudied disease compared with the predominant histological subtype, invasive ductal carcinoma. Hallmarks of...